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Abstract. p8 l, a protein-tyrosine kinase substrate pre- 
viously identified in epidermal growth factor-treated 
A431  cells, is demonstrated to be homologous to 
ezrin, an 80-kD component of microvillar core pro- 
teins. 181  has been characterized using antiserum 
raised against purified chicken intestinal ezrin, p81, 
located by indirect immunofluorescent staining, is 
concentrated in surface projections of A431 cells such 
as microvilli and retraction fibers. None of the condi- 
tions of biochemical cell fractionation tested com- 
pletely solubilizes p81; the insoluble p81  partitions as 
if associated with the cytoskeleton. The soluble form 
of p81  behaves as a monomer in all extraction proce- 
dures studied. EGF-stimulated phosphorylation of p81 
does not appear to change its intracellular location. 
p81  exhibits a wide tissue distribution with highest 
levels of expression in small intestine, kidney, thymus, 
and lung. Intermediate levels are found in spleen, thy- 
mus, lymph nodes, and bone marrow, with low levels 
in brain, heart, and testes, p81  is undetectable in mus- 
cle and liver. In A431 cells, p81  is phosphorylated on 
serine and threonine residues. Upon EGF treatment, 
10% of p81  becomes phosphorylated on tyrosine, 
and the phosphorylation of threonine residues in- 
creases. 
p  HOSPHORYLATION  of proteins on tyrosine residues is a 
rare  event in most normal cells (33). However, cells 
respond to the growth factors, epidermal growth factor 
(EGF)  ~ and platelet-derived  growth factor, with an increase 
in protein-tyrosine kinase activity as manifested by an eleva- 
tion of phosphotyrosine in cellular protein (10, 34). There is 
a similar 5-10-fold increase  in the phosphotyrosine content 
of cells transformed by acutely oncogenic retroviruses  that 
encode protein-tyrosine kinases (33,  35,  50). Incubation of 
some normal cell lines with sodium orthovanadate, an inhib- 
itor of phosphotyrosine-specific  phosphatases, also leads to an 
increase  in cellular phosphotyrosine and to transformation 
(39). These data suggest that phosphorylation of cellular pro- 
teins on tyrosine is involved in controlling cell growth and 
transformation (50). Some protein-tyrosine kinase substrates 
are likely to be proteins directly involved in regulating these 
processes. 
Few substrate proteins for protein-tyrosine kinases have 
been identified. Three, lactate dehydrogenase, phosphoglyc- 
crate mutase, and enolase, are phosphorylated in transformed 
i Abbreviations  ttsed in this paper. DME, Dulbecco's modified Eagle's medium: 
EGF, epidermal  growth factor:  pp81,  phosphorylated  p81; RIPA-VF, buffer 
containing  10  mM sodium  phosphate,  pH 7.0. 0.15 M NaC1, 1%  SDS, 1% 
Nonidet P-40.0.1%  sodium deoxycholate, 1% Trasylol, 2 mM EDTA, 100 #M 
Na3VO4 and 50 mM NaF. 
chick cells and have known enzymatic functions (15). How- 
ever, it has not yet been possible to demonstrate a change in 
function accompanying their phosphorylation. Other cellular 
proteins found to contain phosphotyrosine are vinculin (51, 
52), and five proteins identified by their apparent molecular 
masses: p50 (5, 33, 46), p42 (18, 26, 40, 43), p36 (9,  10, 21, 
34, 47), p35 (23), p81 (12, 13, 16, 34, 36), and p41 (10; Freed, 
E., personal communication). Functions have not yet been 
assigned to these latter proteins, and thus it has been difficult 
to assess the effect, if any, of their phosphorylation on cellular 
phenotype. Much work has been directed toward understand- 
ing the function of these proteins to ascertain whether their 
phosphorylation plays a role in transformation, mitogenesis, 
or differentiation. 
In this study we demonstrate that p81 is homologous to an 
80-kD protein purified from chicken intestinal epithelial cells 
(3,  4).  This  80-kD  protein,  now  called  ezrin,  is  a  minor 
component of the isolated microvillar cores  of these brush 
border cells (3). Its location suggests it plays a structural role, 
but its exact function is not yet clear. Ezrin is present in a 
wide variety of cultured cells where it has been localized to 
cell surface structures (3). Phosphorylated p81 (pp81) was first 
detected in A431 cells, a human epidermoid carcinoma cell 
line,  where a  large increase  in its phosphotyrosine content 
was  observed  after EGF treatment (34). Phosphotyrosine- 
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sarcoma virus (ST-FeSV) transformed A431  cells  and  ST- 
FeSV transformed NIH  3T3 cells  (16,  36).  The homology 
between ezrin and p81 has allowed us to study the intracellular 
location and tissue distribution of p81  and compare it with 
that  of another protein-tyrosine kinase  substrate,  p36.  In 
addition, we have characterized the phosphorylation sites in 
pp81  from A431  cells. 
Materials and Methods 
Cells and Antisera 
A431 cells were grown in Dulbecco's modified Eagle's medium (DME) supple- 
mented with 10% calf serum. LIMI215 cells (55), a human colonic tumor line, 
were grown  in  RPM1 supplemented  with  10%  fetal calf serum,  0.6  ~g/ml 
insulin, 1 ug/ml dexamethasone,  and 10  -5 M a-thioglyeerol. Rabbit anti-ezrin 
serum was prepared against purified chick intestinal ezrin as previously reported 
(3). Antiserum  was used at a  1:200 dilution  for Western blotting, and immu- 
noprecipitations  were performed with antiserum  in excess. For use in indirect 
immunofluorescence  and  indirect  immunoperoxidase  staining,  anti-ezrin  Ig 
was affinity purified as described and used at 32/~g/ml  (3). Anti-p36 serum 
was prepared against partially purified chicken fibroblast protein  and used as 
previously  reported  (14). Anti-fodrin  serum was  prepared  against  purified 
porcine brain fodrin (28) and was used in excess for immunoprecipitation. 
Biosynthetic Labeling and Immunoprecipitation 
Subeonfluent cells were labeled by incubation with 50 uCi/ml or l mCi/ml for 
peptide mapping [3~S]methionine  (>l,000 Ci/mmol, Amersham Corp., Arling- 
ton Heights, IL) at 37"C for 18 h in methionine-free DME supplemented with 
5% calf serum and 5%  DME or by incubation  with 2-3 mCi/ml 32p-ortho- 
phosphate (ICN Radiochemicals, Irvine, CA) at 37"C for 16-18 h in phosphate- 
free DME supplemented  with 4% calf serum.  Where indicated, EGF (Potter, 
S., The Salk Institute)  was added  at 60 ng/ml for  10  min at the end  of the 
labeling period.  Cells were washed  three  times  in  cold  Tris-buffered  saline 
before solubilization  in either 400 ~1 for each 35-ram dish of cold RIPA-VF 
buffer (10 mM sodium phosphate, pH 7.0, 0.15 M NaC1, 1% SDS, 1% Nonidet 
P-40, 0.1% sodium deoxycholate,  1% Trasylol (Mobay Chemical Corp., Pitts- 
burgh, PA), 2 mM EDTA,  100 taM Na~VO4, and 50 mM NaF) or 100 tal for 
each 35-mm dish ofSDS lysis buffer ( 10 mM sodium phosphate, pH 7.2, 0.5% 
SDS, 1 mM EDTA,  1 mM dithiothreitol,  and 1% Trasylol). In the latter case, 
the lysate was prepared at room temperature  and heated for 2 rain at 100*C. 3 
vol of cold RIPA-VF was then added  before centrifugation  (20,000 g for 60 
min at 4"C) and immunoprecipitation  of the supernatant,  lmmunoprecipitao 
tions were performed as previously described (49). Alkali treatment  of SDS gels 
was performed as detailed earlier (17). 
Quantitation of  p81 in A431 Cells 
p81 was immunoprecipitated  from lysates of A431 cells labeled for 18 h with 
[35S]methionine using excess anti-ezrin serum,  lmmunoprecipitates  were re- 
solved on SDS polyacrylamide gels that were impregnated with 2,5-diphenylox- 
azole, p81  was detected by fluorography, and gel bands corresponding to p81 
were cut out and dissolved in 0.2 ml 70% perehloric acid and 0.4 ml 30% H202 
overnight at 60"C before scintillation counting.  The ratio of recovered counts 
in each protein band to the total acid-precipitable counts used for immunopre- 
cipitation gave an estimate of the abundance  of p81. 
Gel Electrophoresis and Western Blots 
Two-dimensional  gel sample preparation  and one- and two-dimensional  elec- 
trophoresis were performed as reported elsewhere (8, 24, 30). lsoelectric focusing 
was performed  with  pH  6-8  or pH  6-8/10  range  ampholytes.  A  detailed 
account of the Western blotting procedure was described previously (30). SDS 
gels were silver stained as reported (42). 
Phosphoamino Acid Analysis and Tryptic 
Peptide Mapping 
lmmunoprecipitated  proteins were resolved on one-dimensional gels, extracted, 
and subjected to either phosphoamino  acid analysis or tryptic digestion (2, 17, 
33). Phosphoamino acids were resolved in two dimensions  by electropboresis 
on 100-~m cellulose thin-layer plates at pH 1.9, followed by electrophoresis at 
right angles at pH 3.5. Phosphopeptides  were resolved in two dimensions  on 
100-tam cellulose thin-layer plates by electrophoresis at pH 1.9 for 25 rain at  1 
kV followed by chromatography  (33). [35S]Methionine-labeled peptides were 
resolved by electrophoresis at pH 4.7 for 27 rain at  l kV followed by chroma- 
tography (2). 
Immunofluorescence Staining 
A431 cells were cultured  on 22-mm  square glass coverslips (some precoated 
with poly-D-lysine) for 40 h before use. They were fixed in phosphate-buffered 
saline (PBS) containing  3%  formaldehyde  for  10 min at 25"C, washed three 
times (5 min each wash) with PBS, permeabilized for 5 min in ice cold 20 mM 
Hepes, pH 7.4, 0.5% Triton  X-100, 300 mM sucrose, 3 mM MgCI2, 50 mM 
NaCI, and rinsed three times for 5 rain with PBS. The coverslips were incubated 
with 20-30 tal of affinity-purified anti-ezrin  Ig at 32 tag/ml for 30 min at room 
temperature, washed three times with PBS for 20 min, and then incubated with 
20-30 gl of a 1:15 dilution of  affinity-purified fluorescein-conjugated goat anti- 
rabbit IgG (Sigma Chemical Co., St. Louis, MO). The coverslips were washed 
three times with PBS for 20 rain and mounted on glass slides with 10 mM Tris- 
HCI, pH 7.4, 0.2 M NAN,, and 90% glycerol, They were viewed with a Nikon 
Optiphot microscope (Nikon  Inc., Garden  City, NY) with episcopic fluores- 
cence attachment  through  a  Plan  APO 40x  oil objective.  Photographs  were 
taken with Kodak Tri-X film. 
Cell Fractionation into Soluble and 
Particulate Fractions 
A431 cell cultures (35-mm dishes) were washed twice with cold Tris-buffered 
saline. The cells were allowed to swell for 10 min at 4"C in 0.4 ml of a solution 
containing 20 mM sodium phosphate pH 7.0, 10 mM NaCI, 10 mM NaF, 100 
~M Na3VO4, 1% Trasylol, 14 mM 2-mercaptoethanol, and either 1 mM EDTA 
or 1 mM MgCI2. They were scraped off the dish and transferred to a Teflon 
tissue grinder (Duall size 20, Kontes Co., Vineland, N  J) and homogenized with 
25 strokes. Cell breakage was monitored by light microscopy. The homogenate 
was transferred  to  airfuge  tubes  and  centrifuged  in  an  Airfuge (Beckman 
Instruments,  Inc., Palo Alto, CA) at  100,000 g for  15  min.  The pellets were 
resuspended  in  the  original  volume  of swelling buffer, and  both pellet and 
supernatant  fractions were adjusted to RIPA-VF conditions. 
Cell Fractionation into Detergent Soluble and 
Insoluble Fractions 
Three procedures were used to define detergent soluble and insoluble fractions: 
(a) A431 cells (35-mm dishes) were extracted on the dish for 3 min at 4"C with 
100 #l of ice-cold 10 mM Pipes pH 6.8, 1% Triton  X-100,  100 mM KCI, 300 
mM sucrose, 50 mM NaF,  100 #M  Na3VO4, 2.5  mM MgCI2, 1 mM CaCI2, 
and 1% Trasylol. Dishes were drained and washed once with 300 tal of  additional 
buffer. Insoluble material was scraped into 400 tal buffer. (b) Same as a except 
that the extraction buffer was ice-cold 10 mM Pipes pH 6.8, 0.5% Nonidet  P- 
40,  100 mM KCI, 300  mM sucrose, 50 mM NaF,  100 taM  Na3VO4, 3 mM 
MgCI2, and  1% Trasylol. (c) Same as a except that the extraction  buffer was 
ice-cold l0 mM 2-(N-morpholino)ethane sulfonic acid pH 6.2, 10 mM NaC1, 
50 mM NaF, 100 taM Na3VO4, 1.5 mM MgCI:, 10% glycerol, and 1% Trasylol 
(buffer M) with 1% Nonidet P-40, 1 mM EGTA, and 5 mM dithiothreitol. All 
fractions were adjusted to RIPA-VF conditions. 
Detergent-insoluble  material  resulting  from  procedure  c was fractionated 
further by a modification of  the procedure reported by Staufenbiel and Deppert 
(54): a  15-min treatment  at 37"C with 400 ~1 buffer M containing  50 tag/ml 
DNase l, a  15-min treatment  at 4°C with 400 ~1 buffer M containing  1 mM 
CaCl2, a 30-min treatment  at 4"C with 400 ~l buffer M containing 2 M NaCI, 
1 mM EGTA, and 5 mM dithiothreitol  and finally the insoluble material was 
dissolved in 400 ~1 RIPA-VF buffer. One-half of each extract was adjusted to 
RIPA-VF buffer for immunoprecipitation.  The other halves were loaded onto 
5 ml  10-30% linear glycerol gradients prepared in the appropriate  buffer and 
centrifuged  in  a  Beckman  SW 50.1 rotor at 40,000 rpm for  19  h.  Parallel 
gradients were prepared  with the  molecular  weight standards  ovalbumin  (43 
kD), bovine serum albumin  (BSA) (68 kD), and rat immunoglobulin  G (150 
kD). Twenty 250-~1 fractions were collected from each gradient. 25 tal of each 
fraction was analyzed directly by SDS PAGE, and the remainder was adjusted 
to RIPA-VF conditions and immunoprecipitated  with anti-ezrin  serum. 
Immunoperoxidase Staining 
The procedures for frozen tissue preparation  and immunoperoxidase  staining 
were exactly as described previously (30). Photographs were taken with Kodak 
technical black and white film. 
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Ezrin Is Homologous to the Protein-Tyrosine Kinase 
Substrate,  p81 
The unphosphorylated form of the phosphotyrosine-contain- 
ing 81-kD protein (p81) in  A431  cells  has been previously 
identified  by  its  migration  on  two-dimensional  gels  (13). 
Because  the  position  of p81  relative to  actin  on  our two- 
dimensional gels was very similar to that reported for intes- 
tinal ezrin (3), we decided to investigate a possible homology. 
To do this we made use of an antiserum raised against chick 
intestinal ezrin that had been shown to react with a similar 
protein in a wide variety of species (3). 
We first determined whether A431 cells contained a protein 
that could be immunoprecipitated by anti-ezrin serum. [35S]- 
Methionine-labeled A431 cells were lysed in RIPA-VF buffer 
and  subjected to  immunoprecipitation with  either nonim- 
mune serum or anti-ezrin serum. After SDS polyacrylamide 
gel electrophoresis, we observed a  predominant, specifically 
immunoprecipitated,  protein  with  an  apparent  molecular 
mass of 81,000 (Fig.  1) that comprised ~0.03% of the total 
[35S]methionine-labeled  protein (see Materials and Methods). 
A minor protein with an apparent molecular mass of 120,000 
was also  specifically  immunoprecipitated (Fig.  1). When ly- 
sates were prepared in SDS lysis buffer rather than RIPA-VF 
buffer, the 120-kD protein was no longer apparent in immu- 
noprecipitates nor was it detected on Western blots. Analysis 
of glycerol gradients, in which R1PA-VF  lysates  of [35S]me- 
thionine-labeled A431 cells had been sedimented, showed the 
81-kD protein to have the sedimentation rate expected for a 
protein this size (data not shown). The 120-kD protein exhib- 
ited a higher sedimentation value than did the 8 l-kD protein, 
indicating that it was  not complexed with this protein but 
rather was recognized independently by the antiserum. Two- 
dimensional tryptic peptide analysis of the [35S]methionine- 
labeled 120-kD protein revealed that it was not related to the 
81-kD protein (data not shown). Furthermore, affinity puri- 
fied  anti-ezrin  Ig  did  not  immunoprecipitate the  120-kD 
protein. Thus, a single 8 l-kD protein in A431 cells appeared 
to be homologous to ezrin. 
Two different experiments were performed to test the relat- 
edness of the  81-kD  protein immunoprecipitated by anti- 
ezrin  serum  and  p81.  For  reference, the  spot  on  a  two- 
dimensional gel  of [35S]methionine-labeled  A431  cells  that 
corresponds to  the  previously identified unphosphorylated 
form of p81 is indicated with an arrow in Fig. 2A (13). In the 
first  experiment, immunoprecipitates of [35S]methionine-la- 
beled A431 cell proteins, prepared either with a nonimmune 
serum or with anti-ezrin serum, were mixed with total unla- 
beled A431 cell proteins and resolved by two-dimensional gel 
electrophoresis. The gels were first silver-stained to display 
the pattern of unlabeled proteins (Fig. 2 B), and labeled pro- 
teins were detected by fluorography (Fig. 2 C). Alignment of 
the fluorographs with  silver-stained gels demonstrated that 
the  81-kD  protein  recognized by anti-ezrin  serum  co-mi- 
grated with p81. In the second experiment, total [35S]methi- 
onine-labeled A431  cell proteins were separated by two-di- 
mensional gel electrophoresis and electrophoretically trans- 
ferred to  a  nitrocellulose sheet.  The blot was  probed with 
anti-ezrin serum followed by t25I-labeled Staphylococcal pro- 
tein A.  125I-Protein A  bound  specifically  to  only one spot, 
which co-migrated with the major unphosphorylated form of 
Figure  1.  Immunoprecipitation  from  A431  cells  using  anti-ezrin 
serum. A431  cells were labeled for 18 h with [35S]methionine,  lysed 
in RIPA-VF buffer, and subjected to immunoprecipitation with either 
anti-ezrin  serum  (lane  1)  or with  nonimmune  serum  (lane  2)  as 
described in Materials and Methods. Immunoprecipitates were ana- 
lyzed by electrophoresis on a  12.5% SDS polyacrylamide gel followed 
by autoradiography.  Arrowheads point to the specifically immuno- 
precipitated proteins. Molecular weight markers are phosphorylase b 
(97 kD), BSA (68 kD), and ovalbumin (43  kD). Exposure time was 
18h. 
p81 (data not shown). 
To establish further the relatedness of the microvillar core 
protein  and  p81,  the  tryptic peptides  of  [35S]methionine- 
labeled p81  immunoprecipitated from LIM 1215 cells, a hu- 
man  colonic tumor cell  line that possesses  microvilli (55), 
primary chicken embryo cells, and human A431  cells were 
compared. The large number of tryptic peptides shared by 
p81 from chicken and human cells (>50%) demonstrated that 
this protein has been highly conserved throughout evolution 
(Fig.  3, A-C). The identical pattern of tryptic peptides gen- 
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gel sample buffer. Proteins were resolved by two-dimensional gel electrophoresis as described in Materials and Methods with pH 6-8 range 
ampholytes and visualized by fluorography (A). In a  second experiment, ~10 #g of protein from unlabeled A431  cells was mixed with a 
[35S]methionine-labeled  anti--ezrin immunoprecipitate from A431  cells and resolved by two-dimensional  gel electrophoresis with pH 6-8/10 
range ampholytes. The gel was silver stained (B) and then subjected to fluorography (C).  Relevant portions of the gels are shown. Note that 
silver staining decreases  the efficiency of fluorography. Acidic proteins are on the left. Arrowheads point to actin (A) and to p81. Exposure 
times were  18 h (A) and 5 d (C). 
Figure 3. Two-dimensional  tryptic peptide maps of p81 from A431, chicken 
embryo, and LIMl215 cells, p81  was immunoprecipitated with anti-ezrin 
serum from [35S]methionine-labeled  A431 cells, LIM 1215 cells, and chicken 
embryo cells and subjected to tryptic cleavage.  The resultant peptides were 
resolved in two dimensions as described in Materials and Methods.  p81 
from:  (A)  A431  cells;  (B)  chicken embryo cells;  (C)  A431  and  chicken 
embryo cells  mixed; (D)  A431  cells;  (E)  LIMI215  cells;  (F) A431  and 
LIM 1215 cells mixed. A-C and D-F are from different experiments. In each 
case the origin is marked with an arrowhead. Electrophoresis was performed 
at pH 4.7 in the horizontal dimension, with the anode on the left.  Plates 
were impregnated with 2-methyl-naphthalene and exposed at -70"C. cpm 
loaded onto thin layer plates and exposure times are as follows: (.4) 18,000 
cpm, 5 d; (B) 3,500 cpm, 2 wk; (C) 3,500 cpm of each,  l0 d; (D) 31,000 
cpm, 3 d; (E) 39,000 cpm, 3 d; (F) 13,000 clam of each, 3 d. 
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indicated  that  no  unusual  modification  of p81  occurs  in 
intestinal cells. 
Intracellular Distribution of  p81 in A431 Cells 
Since ezrin was purified  as a  component of the  microvillar 
core (3), we anticipated that p81 would be found in microvilli 
of A431 cells and would behave in biochemical fractionations 
as  if it  were  a  component  of the  A431  cytoskeleton.  We 
attempted  to  confirm  these  predictions  with  both  indirect 
immunofluorescence and  biochemical  fractionation.  In ad- 
dition, we asked whether or not EGF treatment and/or phos- 
phorylation altered the distribution of p81. 
Because of  the unwanted specificity in the anti-ezrin serum 
towards  the  unrelated  120-kD  protein,  affinity-purified  Ig 
which does not recognize this protein was used for immuno- 
fluorescence staining, p81  in A431 cells was concentrated in 
surface  projections  such  as  microvilli  and  retraction  fibers 
(Fig. 4). This pattern was more pronounced when cells were 
grown on  poly-D-lysine-coated coverslips  (Fig.  4 C).  It was 
not detectable  unless the cell  membrane was permeabilized 
(data not shown). This pattern of p81  staining in A431 cells 
is similar to that observed in other tissue culture cells (3). 
To determine  the degree of association between p81  and 
the cytoskeleton, three  different detergent extraction  condi- 
tions reported to leave the cytoskeleton intact were applied to 
A431 cells (6,  11, 54). [35S]Methionine-labeled or 32p-labeled 
cells treated with or without EGF were extracted under these 
three conditions. In addition, we determined whether or not 
p81  was in the soluble or particulate  fractions of cells lysed 
by homogenization after swelling in hypotonic buffers con- 
taining  either  MgCl2  or EDTA.  After all  the  fractions had 
been adjusted to RIPA-VF conditions, p81 was immunopre- 
cipitated with excess anti-ezrin serum, and the percentages of 
p81  in each  fraction were  estimated  by counting gel bands 
and scanning autoradiographs (Table I). Between 37 and 61% 
of p81 was insoluble depending on the procedure. The distri- 
bution  of the  phosphorylated  form"  of the  protein  (pp81) 
paralleled that of the total p81 population. In addition, treat- 
ment  of the  cells  with  EGF  did  not  appear  to  alter  the 
distribution of p81  (Table I). The greatest percentage of p81 
was  found associated  with  the  cytoskeleton prepared  using 
procedure c (see Materials and Methods). This insoluble ma- 
terial was further fractionated by incubation with  DNase I, 
followed by a  Ca  2+ extraction, and then a  2 M  NaC1 extrac- 
tion. SDS polyacrylamide gel analysis of proteins from each 
extract and the residual material illustrated that each extract 
contained a significantly different population of  proteins (data 
not shown).  This suggested that nonspecific leaching out of 
proteins during this  long procedure was minimal.  As addi- 
tional controls, the fractionation properties of fodrin, a  cor- 
tical  cytoskeletal protein  (27),  and  another  protein-tyrosine 
Figure 4. Indirect  immunofluorescent  staining with affinity-purified anti-ezrin Ig in A431 cells. A431 cells were grown on glass coverslips 
uncoated (A) or coated (C) with poly-D-lysine.  They were incubated with affinity-purified anti-ezrin lg followed by affinity-purified fluorescein- 
conjugated goat anti-rabbit lgG as described in Materials and Methods. Nomarski images of  A and C are shown in B and D, respectively. Bar, 
12 ~m. 
The Journal of Cell Biology, Volume  102, 1986  664 Table  L  Distribution of  p81 and pp81 between A431 
Cell Fractions 
p81  pp81 
-EGF  +EGF  -EGF  +EGF 
% particulate 
Detergent lysis 
Procedure a  42  45  57  60 
Procedure b  37  43  52  56 
Procedure c  61  68  69  71 
Hypotonic lysis 
Mg  2÷  48  54  49  46 
EDTA  56  59  52  48 
A431  cells were labeled with [35S]methionine or 32p-orthophosphate  and were 
either untreated or treated with EGF at 60 ng/ml for 10 rain. The cells were 
lysed according to one of five procedures detailed in Materials and Methods 
and separated into soluble and particulate fractions.  All resultant fractions were 
adjusted to  RIPA-VF conditions, asS-labeled p81  and a2p-labeled 19p81 were 
immuno19reci19itated  from each fraction and resolved on 12.5% polyacrylamide 
gels. After fluorography or autoradiogra19hy, the percentages of asS-labeled p81 
and 32p-labeled 19p81 in each fraction were determined by counting solubilized 
gel bands and by scanning autoradiographs. Only values for the particulate 
fractions are shown, There is about five times more 191981 in EGF-treated A431 
cells than in control cells (see Fig. 8). The data for distribution of 1981 include 
only a small (-10%) contribution from p1981. The numbers provided for 32p. 
labeled  p1981 are the average of results obtained by the two methods of data 
analysis described from one experiment. This experiment was repeated with 
visually  similar  results several  times but  was  quantitated  only once.  The 
numbers given for aSS-labeled 1981 represent the average of two separate quan- 
titated experiments. The error in the calculated percentages is +5%. 
Table  II.  Distribution of  Fodrin, p81, and p36 in Sequential 
Extractions  ofA431 Cells 
Extractions  Fodrin  p81  1936 
1% Nonidet P-40  27  21  29 
50 ug/ml DNase I  9  18  20 
1 mM Ca  2÷  5  19  4 
2  M  NaC1  13  19  22 
Residual material  46  23  25 
A431  monolayers were  labeled  with [3SS]methionine and extracted according 
to procedure c detailed in Materials and Methods. The particulate material was 
extracted further with 50 #g/ml DNase 1, then 1 mM Ca  2÷, and fin,-Ily 2 M 
NaCI as described in  Materials and Methods. Residual material was scraped 
off the dish, and all  fractions were adjusted to RIPA-VF conditions. Fodrin, 
1981, and 1936 were immunopreci19itated  together from each fraction, and the 
immunopreci19itates  were resolved  by SDS polyacrylamide gel electrophoresis. 
After fluorography, bands corresponding to each protein were cut out, solubi- 
lized,  and counted. The values in each column represent the fraction of the 
protein recovered  at each step expressed as a percentage of the total. The error 
in the calculated percentages is +5%. 
kinase substrate, p36, were monitored as well. p36 is known 
to associate with particulate fractions of cells (7, 11) in a Ca  2÷- 
dependent  manner (25,  29) and  to be located at the  inner 
surface of the plasma membrane (20,  31,  44,  48).  The per- 
centages of fodrin,  p81,  and  p36  found  in  each secondary 
fraction are  listed  in  Table II.  Some p81  was found  in  all 
fractions. Like fodrin and actin, a high percentage was soluble 
under all fractionation conditions used. p36 was found in all 
but  the  Ca  2÷ extract.  Relatively few proteins were released 
during the Ca  2÷ and DNase I extractions but fodrin and actin 
were. Thus, p81 shared some fractionation characteristics with 
bona  fide  cytoskeletal  proteins.  At  least  37%  of p81  was 
resistant to detergent extraction and could be released only 
when cytoskeletal elements were disrupted. 
As p81  was released in procedure c by agents that disrupt 
cytoskeletal elements, we tested whether p81 might be released 
in association with another protein during extraction. Samples 
of each extract were separated  on glycerol gradients in  the 
appropriate buffers. Portions of each gradient fraction were 
run directly on SDS polyacrylamide gels, while the remainder 
was adjusted  to  RIPA-VF conditions and subjected to im- 
munoprecipitation  with  anti-ezrin  serum.  As  an  example, 
immunoprecipitations  of  the  gradient  fractions  from  the 
DNase  I  extract  are  shown  in  Fig.  5.  p81  behaved  as  an 
unassociated monomer in all extracts.  If it were complexed 
with another protein,  that  protein  would  have to  be small 
enough so as not to cause a detectable shift in the sedimen- 
tation of p8 I. Alternatively, its association with another pro- 
tein might be sensitive to the hydrodynamic forces encoun- 
tered during the centrifugation. 
p81 Shows a  Wide Tissue Distribution 
Since ezrin was purified from the apical region of intestinal 
epithelial cells where p36 appears to be concentrated (25, 30, 
32), we looked to see if the overall tissue distribution of p81 
was  identical  to  that  of p36.  To  determine  which  mouse 
tissues  expressed  p81,  Western  blots  containing  equal 
amounts of proteins from several mouse tissues were probed 
with  anti-ezrin  serum  followed by  ~2SI-protein A  (Fig.  6). 
Small intestine, thymus, kidney, and lung expressed the high- 
est levels of p81; bone marrow, spleen, and lymph nodes had 
lower levels; p81  was scarce in brain, heart, testis,  and fascia; 
and p81 was undetectable (<2% of  the level in small intestine) 
in muscle and liver. This distribution was similar, though not 
identical to that of p36 (30). 
In the small intestine  and kidney,  ezrin expression is re- 
stricted  to  the  microvilli  of epithelial  cells  (3;  Allen,  R., 
Figure  5.  Glycerol  gradient  analysis of p81  released  by  DNase  I 
treatment of A431  particulate proteins. A431  cells were labeled with 
[35S]methionine,  extracted  according  to  procedure  c  (see  Materials 
and Methods), and the residue extracted further as detailed in Mate- 
rials and  Methods.  Each  extract  was separated on  a  5  ml  10-30% 
glycerol  gradient  in  parallel  with  the  molecular  weight  standards, 
ovalbumin (43 kD), BSA (68 kD), and rat immunoglobulin (150 kD). 
20 fractions were collected from each gradient, and p81  was immu- 
noprecipitated from each after they were adjusted to RIPA-VF con- 
ditions, lmmunoprecipitates were resolved on a  12.5% polyacrylam- 
ide gel, and the gel was subjected to fluorography. The results of one 
gradient,  the  material  released  by  50  ug/ml  DNase  I  treatment  as 
shown here.  p81  was found in fractions where a  monomeric 8 l-kD 
protein  should sediment. The arrow  indicates the direction  of sedi- 
mentation. Exposure time was 18 h. 
665  Gould et al. Protein- Tyrosine Kinase Substrate p81 Figure 6.  Western blot of adult mouse tissues.  Protein from each 
tissue  was  resolved  on  a  15%  polyacrylamide gel.  Proteins were 
electrophoreticaily  transferred to nitrocellulose  sheets, incubated with 
anti-ezrin serum, and then probed with ~SI-protein A. Lane 1, 2 ~zg 
small intestine; lane 2,  5  ~g small intestine; lane 3,  10  ug  small 
intestine; lane 4, 20 ug small intestine. Lanes 5-17 were loaded with 
20 #g of protein from: lane 5, brain; lane 6, liver; lane 7, kidney; lane 
8, lung; lane 9, heart; lane 10, thigh muscle; lane 11, fascia; lane 12, 
bone marrow cells; lane 13, spleen;  lane 14, lymph node; lane 15, 
thymus; lane 16, testes; lane 17, urinary tract. Exposure time was 18 
h with an intensifying screen at -70"C. 
personal communication).  To determine whether there is a 
subpopulation of cells that accounts for the high expression 
of p81  in thymus and spleen, frozen tissue sections of each 
organ from rat were prepared for indirect immunoperoxidase 
staining using affinity-purified anti-ezrin Ig. Stained sections 
of each organ are shown in Fig. 7. In the spleen, periarteriolar 
lymphocytes stain strongly as do small B cells and large B cell 
blasts. Some lymphocytes in  the red pulp are also positive. 
Structural cells and megakaryocytes  were weakly positive. Red 
cell and white cell precursors, red cells, and endothelial cells 
do not stain (Fig. 7A). In the thymus, p81  is most prevalent 
in subcapsular lymphocytes (Fig. 7 B). Lymphocytes from the 
medulla stain more strongly than those from the cortex. The 
epithelial reticular cells are weakly reactive. These data suggest 
that the expression of p81  is not restricted to cell types with 
highly organized microvilli. 
p81  Can Be Phosphorylated on Serine,  Threonine, 
and Tyrosine Residues 
Using  the  anti-ezrin  serum,  we  investigated the  phospho- 
rylation state of p81  in A431  cells. Subconfluent A431  cells 
were labeled with 32P-orthophosphate at 37"C  for  18  h  and 
then treated with EGF for  10  rain. After lysis of the cells in 
Figure 7. Indirect immunoperoxidase staining of p81 in rat spleen and thymus. Frozen tissue sections of rat spleen (A and B) and rat thymus 
(C and D) were incubated with afffinity-purified anti-ezrin lg followed by affinity-purified  horseradish peroxidase-conjugated  goat anti-rabbit 
IgG and diaminobenzidine as described in Materials and Methods (A and C). B and D show photographs of similar sections stained only with 
the second layer antibodies and diaminobenzidine. Bar, 12 #m. 
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serum (Fig.  8A).  Untreated cells contained detectable  levels 
of phosphorylated p81.  EGF treatment  increased the phos- 
phate labeling of p81  about fivefold (Fig. 8A, lanes 1 and 2). 
When the gel shown in Fig. 8A was then incubated in alkali 
to enhance detection of phosphothreonine and phosphotyro- 
sine residues (Fig. 8 B), alkali-stable radioactivity was detect- 
able in  pp81  from untreated  cells,  pp81  from unstimulated 
cells,  isolated in the presence of phosphatase inhibitors,  was 
found  to  contain  phosphoserine  and  phosphothreonine, 
whereas  pp81  from  EGF-stimulated  cells  contained  phos- 
phoserine,  an  increased  amount  of phosphothreonine,  and 
phosphotyrosine (Fig. 8 C, a  and b). Alkali-stable radioactiv- 
ity, however, was only detectable in pp81 from untreated cells 
if phosphatase  inhibitors  were  included  in  the  lysis buffer. 
This would explain  our earlier  results  where  pp81  was not 
detected on alkali-treated  two-dimensional gels of untreated 
cells (34). Apparently a  phosphothreonine-specific phospha- 
tase in A431  cells is active on pp81  during two-dimensional 
gel sample preparation and also in unmodified RIPA buffer. 
The fraction of p81  newly modified at tyrosine in response 
to  EGF treatment  was estimated  in  the  following manner. 
Anti-ezrin  immunoprecipitates  of  [3SS]methionine-labeled 
control and EGF-stimulated A431 cells (prepared in unmod- 
ified RIPA buffer and thus lacking detectable levels of phos- 
phothreonine)  were  resolved  on  two-dimensional  gels.  The 
fluorographs of  these gels were quantified by two-dimensional 
computer-assisted densitometry. The percentage of phospho- 
rylated p81,  which migrates to a  more acidic position than 
the majority of the protein, was calculated to be 10% in EGF- 
treated cells.  This percentage represents a minimum estimate 
since it is likely that some phosphotyrosine was lost in addi- 
tion  to  the  phosphothreonine  due  to  protein  phosphatase 
action in unmodified RIPA buffer. 
The  phosphorylation  sites  of pp81  were  investigated  by 
two-dimensional tryptic  peptide  analysis of pp81  immuno- 
precipitated in the presence of phosphatase inhibitors,  pp81 
isolated  from control cells contained three  major phospho- 
peptides termed l, 2, and 3 (Fig. 9A). Phosphopeptides 1 and 
2 contained only phosphothreonine, whereas phosphopeptide 
3 contained phosphothreonine and phosphoserine (data not 
shown),  pp81  from stimulated  cells contained phosphopep- 
tides  1-3 and one major new phosphopeptide termed phos- 
phopeptide  4  (Fig.  9B).  Phosphopeptide 4  contained phos- 
photyrosine exclusively (data not shown). 
Discussion 
In this study, we have characterized a protein-tyrosine kinase 
substrate in A431  cells that has a  molecular mass of 81,000. 
p81  is homologous to the intestinal  protein ezrin, and may 
indeed  be  identical.  Like ezrin  in  intestinal  epithelial  cells, 
p81 is localized in the submembranous cortical skeleton where 
it is concentrated in microvilli. We obtained no evidence that 
p81  is specifically associated with any other cellular protein. 
Figure 8. lmmunoprecipitations of p81 from 32p-labeled A431 cells 
and phosphoamino acid analysis of the immunoprecipitates.  A431 
cells were labeled with 32P-orthophosphate, lysed in RIPA-VF buffer, 
and pp81 was immunoprecipitated  from untreated  cells (lane 1 in A 
and B) and EGF-treated  cells (lane 2 in A and B) as described in 
Materials and Methods. The immunoprecipitates  were resolved on a 
12.5% SDS polyacrylamide  gel, and pp81 was detected  by autora- 
diography  (panel A). After alkali treatment of the gel shown in A, 
alkali-stable phosphoproteins  were detected by autoradiography  (B). 
Arrowheads  indicate  pp81.  Gel  bands  containing  pp81 from un- 
treated and EGF-treated  cells comparable  to those shown in A were 
analyzed for their phosphoamino acid content as described in Mate- 
rials and Methods. C, insert a, shows the phosphoamino acids derived 
from pp81 from untreated  A431 cells. C, insert b, shows the phos- 
phoamino acids derived from pp81 from EGF-treated cells. Cerenkov 
cpm applied  to thin  layer plates were in C, insert a,  100 cpm, and 
180 cpm in C, insert b. p-SER, phosphoserine; p-THR, phosphothre- 
onine; p-TYR, phosphotyrosine.  Exposure times were as follows: A, 
18 h; B, 3 d; and C, at -70"C with an intensifying screen, 3.5 d. 
Figure  9.  Two-dimensional  tryptic  phosphopeptide  maps of pp81 
from untreated  and EGF-treated A431 cells, pp81 was isolated from 
equal  numbers of untreated  or EGF-treated  32p-orthophosphate-la- 
beled A431 cells, subjected to tryptic digestion, and separated in two 
dimensions as described in Materials and Methods. In each case the 
origin is marked  (arrowhead). Electrophoresis was performed in the 
horizontal dimension at pH 1.9, with the anode on the left. A shows 
the  tryptic  phosphopeptides  of pp81 from untreated  cells, and  B 
shows the tryptic phosphopeptides  of pp81 from EGF-treated  cells. 
Cerenkov cpm loaded onto thin  layer plates was 400 cpm in A and 
1,400 cpm in B. Exposure time at -70"C with an intensifying screen 
was 2 d. 
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In the mouse, p81  is found in a wide variety of tissues. 
In many ways our findings with p81 parallel what is known 
about another protein tyrosine kinase substrate, p36.  First, 
both  are  concentrated  in  the  apical  cytoskeletal  region  of 
intestinal brush border cells (2.5, 30, 32), indicating that they 
are associated with structural  components,  p81, and  under 
some conditions p36 (7,  11, 48), fractionate with cytoskeletal 
elements when tissue culture cells are extracted with detergent. 
These properties are consistent with the notion that p81  and 
p36 are either part of the cytoskeletal framework or associated 
with  cytoskeletal  proteins  in  detergent-insoluble  fractions. 
However, we have been unable to demonstrate binding of 
soluble p81 to other proteins in sedimentation studies under 
a  variety of conditions.  Similarly, reconstitution  studies of 
microvillar core  proteins  have  not  provided  evidence  for 
specific association with other proteins (Bretscher, A, unpub- 
lished results),  p81  binding to detergent-insoluble fractions is 
not  divalent cation  dependent.  This is in  contrast to p36, 
which has been found in dimeric form in association with a 
10-kD protein (22, 25) and has also been shown to bind actin 
and fodrin in a  Ca2+-dependent manner (25,  29).  The frac- 
tionation properties of p81  do not appear to change signifi- 
cantly  when  the  protein  is  phosphorylated in  response  to 
EGF. However, without a  more complete understanding of 
the function of p81, subtle changes in distribution or associ- 
ations cannot be ruled out. 
As well as exhibiting similar intracellular distributions, p81 
and p36 appear to have similar anatomical distributions in 
the mouse. Both proteins are expressed at very low levels in 
brain, muscle, and liver with high levels in intestine, thymus, 
and lung (30).  Neither protein co-distributes in tissues with 
any known  protein-tyrosine kinase  (1,  19,  37,  53,  56),  al- 
though in A431  cells examined by indirect immunofluores- 
cence, the distributions of p81  and p36 overlap that of the 
EGF receptor (Gould, K. L., unpublished results). This would 
be consistent with p81 being a primary substrate for the EGF 
receptor protein-tyrosine kinase. We do not yet know if there 
is an active protein-tyrosine kinase located in the small intes- 
tine or if p81  or p36 is phosphorylated on tyrosine there. 
The results of the gross anatomical survey concealed some 
differences between p81  and p36 that were found when the 
cell  types  expressing  each  protein  were  identified.  In  the 
thymus, for example, p36  is located predominantly in  the 
structural framework of the organ (30), whereas p81 is found 
in the lymphocytes and only at low levels in the epithelial 
cells.  In addition the level of p81  in kidney is considerably 
higher than  that  of p36.  This  may be  of relevance in  the 
microvillar structures of kidney proximal tubules. 
p81 is phosphorylated in A431 cells on serine and threonine 
residues. In response to EGF,  ~ 10%  of the protein is addi- 
tionally phosphorylated on tyrosine residues, and the extent 
of threonine phosphorylation increases. Tryptic digestion of 
pp81 from EGF-treated cells reveals only one major phospho- 
tyrosine-containing peptide, suggesting a single site of tyrosine 
phosphorylation. This study of the phosphorylation sites in 
p81 demonstrated the need for specific phosphatase inhibitors 
in lysis buffers. In the absence of sodium fluoride and sodium 
orthovanadate, pp81  from untreated cells was barely detect- 
able and contained only phosphoserine. In response to EGF, 
p81  was additionally phosphorylated on tyrosine. However, 
when isolated in the presence of phosphatase inhibitors, pp81 
from  untreated  cells was  readily detectable  and  contained 
phosphothreonine and phosphoserine. Its phosphorylation on 
threonine  as  well  as  on  tyrosine  was  stimulated  by  EGF 
treatment. Phosphorylation of  the threonine site(s) is probably 
not due to activation of protein kinase C in EGF-treated A431 
cells as  purified  p81  is  neither  phosphorylated by protein 
kinase C  in vitro nor phosphorylated to a  greater extent in 
vivo in response to tumor promoters (Gould,,K. L., and J. 
Meisenhelder,  unpublished  results).  It is also worth  noting 
here that despite their similarity in size and subcellular loca- 
tion, p81  is unlikely to be protein kinase C. Indirect evidence 
for this includes their very different tissue distributions (41), 
their different pls (38), their distinct intracellular distributions 
(45),  and  the  inability  of purified p81  to  act  as  a  protein 
kinase in  vitro.  More direct evidence is the  disparate two- 
dimensional phosphopeptide maps of the two proteins (our 
unpublished results). 
p81  appears to be the product of a  single  gene.  In vitro 
translation  of poly A-containing  RNA  from a  number of 
rodent cell and tissue sources followed by immunoprecipita- 
tion yielded a single protein that in every case co-migrated on 
one- and two-dimensional gels with p81  from metabolically 
labeled  rodent  cells  (Saris,  C.,  personal  communication). 
Thus,  the  protein  does  not  appear to  be  synthesized  as  a 
precursor, p81  is also a very stable protein with a half-life of 
~17  h.  Although it is abundant,  comprising -0.03%  of the 
total cell protein in A431  cells, it is 5-10-fold less abundant 
than p36 (17,  47).  Due to this lower abundance, pp81  may 
have been overlooked in other studies searching for substrates 
of tyrosine  phosphorylation.  Indeed,  by immunoprecipita- 
tion, but not by two-dimensional gel analysis, we have been 
able to identify a phosphotyrosine-containing form of p81  in 
Rous sarcoma virus-transformed chicken cells (Gould, K. L., 
unpublished  results).  We  are  currently  investigating  under 
what other conditions p81  is phosphorylated on tyrosine. 
Without  a  functional  assay  for  p81  we  cannot  assess 
whether phosphorylation of p81 is likely to be of consequence 
in the response of cells to EGF or in  viral transformation. 
The relatively low stoichiometry of p81  tyrosine phospho- 
rylation could be of significance if a critical subpopulation of 
the protein were phosphorylated. Alternatively p81  might be 
phosphorylated gratuitously as a consequence of its proximity 
to a variety of membrane-associated protein-tyrosine kinases. 
The answer to this question must await further studies on the 
structure and function of p81. 
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